Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best
GLP-1 medicines are set to revolutionize public health with over $100 billion in annual revenue potential. The post Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best appeared first on Crypto Briefing.
Original Source
Read the full article at Cryptobriefing →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.